Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
With installations now 200-strong worldwide, StorageTek at HIMSS demonstrated its StreamLine SL8500 Modular Library System for information lifecycle management.
Wireless voice communications firm Vocera Communications Inc. at HIMSS displayed its Vocera Nurse Call Integration Module as part of its hands-free, voice-controlled communications system.
Per-Se Technologies Inc. at last week's HIMSS meeting launched a new class of services to help healthcare organizations navigate the business environment.
Voxar is showcasing new visualization for its 3D software at the European Congress of Radiology (ECR) that begins Friday and runs through Tuesday in Vienna, Austria.
U.S. healthcare facilities are expected to turn to wireless technologies to help solve the problems of rising patient volumes, acute staff shortages and a rapidly aging population.
Some 72 percent of hospital and health system CFOs surveyed said they plan to purchase digital radiology systems, while 61 percent (of the 460 surveyed) expect to buy information technology (IT) systems over the next five years -- signaling the beginning
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
